SCHEMBL8018148

SCHEMBL8018148

CC(C)(NCc1ccccc1Oc1ccccc1)C(=O)Nc1ccc(C#N)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.51
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
ALOX15 P16050 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
PDK1 Q15118 1/20 0.39
PDK2 Q15119 1/20 0.39
PDK3 Q15120 1/20 0.39
PDK4 Q16654 1/20 0.39
CHEK1 O14757 2/20 0.39
KCNQ3 O43525 2/20 0.38
KCNQ2 O43526 2/20 0.38
RIPK1 Q13546 1/20 0.38
KCNE1 P15382 1/20 0.38
KCNQ1 P51787 1/20 0.38
HTR2A P28223 1/20 0.37
SLC6A4 P31645 1/20 0.37
PKM P14618 1/20 0.37
BRAF P15056 1/20 0.37
CASP3 P42574 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8019561 0.76 CYP3A4 (0.42) ALOX15KDM4CPDK1PDK2PDK3
SCHEMBL8018561 0.74 AR (0.47) ARPDK1PDK2PDK3PDK4
SCHEMBL8016868 0.74 AR (0.52) AR
SCHEMBL8006388 0.72 RAF1 (0.44) PDK1PDK2PDK3PDK4RIPK1
SCHEMBL1192098 0.70 RIPK1 (0.49) ALOX15KDM4CRIPK1HTR2ASLC6A4
SCHEMBL22957883 0.70 RIPK1 (0.62) MEN1KMT2AALOX15KDM4CRIPK1
SCHEMBL896642 0.70 ALDH1A1 (0.52) ARMEN1KMT2ACHEK1KCNQ3
SCHEMBL30136739 0.70 ALDH1A1 (0.52) ARMEN1KMT2ACHEK1KCNQ3
SCHEMBL8026319 0.69 GAA (0.51) MEN1KMT2APKM
SCHEMBL30171207 0.68 AR (1.00) ARKCNQ3KCNQ2BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009097998-A1 ARYLCHALCOGENO-ARYLALKYL-SUBSTITUTED IMIDAZOLIDINE-2,4-DIONES, METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF SANOFI-AVENTIS (FR) 2009-08-13 WO disclosed